CompletedPhase 3NCT00430807

Hydroxychloroquine in Giant Cell Arteritis

Studying Giant cell arteritis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Toulouse
Principal Investigator
ARLET Philippe, D
CHU Toulouse, Hôpital Purpan
Intervention
hydroxychloroquine/placebo(drug)
Enrollment
75 enrolled
Eligibility
18-85 years · All sexes
Timeline
20022006

Study locations (23)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00430807 on ClinicalTrials.gov

Other trials for Giant cell arteritis

Additional recruiting or active studies for the same condition.

See all trials for Giant cell arteritis

← Back to all trials